Invention Grant
- Patent Title: Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer
-
Application No.: US14925534Application Date: 2015-10-28
-
Publication No.: US09765147B2Publication Date: 2017-09-19
- Inventor: Brian Wong , Julie Hambleton , Robert Sikorski , Emma Masteller , Kevin Hestir , David Bellovin , Katherine E. Lewis
- Applicant: Five Prime Therapeutics, Inc. , Bristol-Myers Squibb Company
- Applicant Address: US CA South San Francisco US NJ Princeton
- Assignee: Five Prime Therapeutics, Inc.,Bristol-Myers Squibb Company
- Current Assignee: Five Prime Therapeutics, Inc.,Bristol-Myers Squibb Company
- Current Assignee Address: US CA South San Francisco US NJ Princeton
- Agency: McNeill Baur PLLC
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/30 ; A61K39/00
Abstract:
Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
Public/Granted literature
- US20160152715A1 COMBINATION THERAPY FOR CANCER Public/Granted day:2016-06-02
Information query
